Project Zenith© will set a new standard in corporate transparency and accountability. We seek to create a new corporate
architecture in which the consumer is the progenitor of the product; in which finance and human beneficence are dual goals
with equal weight. Project Zenith© will pave the way for a world in which mental health and a new social alignment will serve
to benefit humanity for a new tomorrow.

Proteins are truly remarkable molecules that may have many different properties. All the various tissues in the body
are mainly made of proteins. Likewise all kinds of regulatory substances such as enzymes, hormones and signal

Unfortunately, the properties of a protein are entirely decided by its form, which is decided by the
sequence of its building blocks, the amino acids. This "gene" is a hinderance to the true potential that proteins

The DNA-protein system is an ingeniously simple and extremely powerful solution for creating biological
properties and structures that are sufficient to generate the enormous variety of biological life. Project Zenith©
affirms that this system combined with the possibilites Euphorine GNR© will set the stage for a new horizon.

Canadian Residents may secure Euphorine GNR and other pharmaceuticals available at a fraction of the regular cost by calling: 1-866-375-2929
FDA's general position: The FDA, due to the current state of their regulations, has taken the position that virtually all shipments of prescription drugs imported from a Canadian pharmacy by a U.S. consumer will violate the law.
This is not an offering to any prospect located in, or for any location in, California, Hawaii, Illinois, Indiana, Maryland, Michigan, Minnesota, North Dakota, Rhode Island, South Dakota, Virginia, Washington, or Wisconsin. An offering can only be made in these states by providing you with a prospectus filed first with the relevant state administrator (in North Dakota, the Department of Law of the State of North Dakota). Any such filing does not constitute approval by the state administrator.